Subsequent Western blot analysis revealed constitutive upregulation of the cyclin-dependent kinase inhibitors p21CIP1 and p27Kip1, suggesting that GBM cell adhesion to ligands prominently expressed in blood clot is crucial for cell-cycle progression. The gene discussed is CDKN1B; the disease is glioblastoma.